Crispr Therapeutics shares owned by Ameriprise Financial
Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Ameriprise Financial
from 13F filings
Historical chart of Ameriprise Financial investment in Crispr Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Crispr Therapeutics held by Ameriprise Financial consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Crispr Therapeutics by Ameriprise Financial
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $20M | 312k | 64.81 |
| 2025-06-30 | $13M | 262k | 49.00 |
| 2025-03-31 | $7.4M | 218k | 34.00 |
| 2024-12-31 | $8.0M | 205k | 39.00 |
| 2024-09-30 | $8.8M | 187k | 47.00 |
| 2024-06-30 | $8.8M | 163k | 54.01 |
| 2024-03-31 | $11M | 157k | 68.09 |
| 2023-09-30 | $5.2M | 115k | 45.40 |
| 2023-06-30 | $7.3M | 129k | 56.13 |
| 2023-03-31 | $3.8M | 83k | 45.23 |
| 2022-12-31 | $2.6M | 57k | 44.44 |
| 2022-09-30 | $6.9M | 104k | 66.06 |
| 2022-06-30 | $3.6M | 59k | 60.77 |
| 2022-03-31 | $3.2M | 54k | 59.70 |
| 2021-12-31 | $3.4M | 46k | 74.63 |
| 2021-09-30 | $38M | 337k | 111.93 |
| 2021-06-30 | $55M | 337k | 161.90 |
| 2021-03-31 | $56M | 466k | 119.40 |
| 2020-12-31 | $67M | 449k | 149.25 |
| 2020-09-30 | $53M | 630k | 83.57 |
| 2020-06-30 | $78M | 1.1M | 73.49 |
| 2020-03-31 | $35M | 816k | 42.41 |
| 2019-12-31 | $29M | 470k | 60.91 |
| 2019-09-30 | $843k | 21k | 40.98 |
| 2019-06-30 | $971k | 21k | 47.12 |
| 2019-03-31 | $853k | 24k | 35.71 |
| 2018-12-31 | $648k | 23k | 28.58 |
| 2018-09-30 | $2.2M | 49k | 44.35 |
| 2018-06-30 | $3.0M | 52k | 57.14 |
| 2018-03-31 | $1.2M | 27k | 43.16 |